The Thyroid Epidemiology, Audit, and Research Study (TEARS): Morbidity in patients with endogenous subclinical hyperthyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 5, 2011, Pages 1344-1351

  Vadiveloo, Thenmalar ^a   Donnan, Peter T ^a   Cochrane, Lynda ^a   Leese, Graham P ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

AGED; ARTICLE; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; ENDOGENOUS SUBCLINICAL HYPERTHYROIDISM; FEMALE; FRAGILITY FRACTURE; HEART ARRHYTHMIA; HUMAN; HYPERTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEOPLASM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; UNITED KINGDOM;

AGE FACTORS; AGED; ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; DATABASES, FACTUAL; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; NEOPLASMS; OSTEOPOROSIS; RISK ASSESSMENT; SCOTLAND; SEX FACTORS; THYROID HORMONES; THYROTROPIN; TREATMENT OUTCOME;

EID: 79955666598     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2693     Document Type: Article

References (21)

1. Vadiveloo T, Donnan PT, Cochrane L, Leese GP 2011 The thyroid epidemiology, audit, and research study (TEARS): the natural history of endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab 96:E1-E8
2. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC 2000 The Colorado thyroid disease prevalence study. Arch Intern Med 160:526-534 (Pubitemid 30112276)
3. Marqusee E, Haden ST, Utiger RD 1998 Subclinical thyrotoxicosis. Endocrinol Metab Clin North Am 27:37-49 (Pubitemid 28144952)
4. Wang C, Crapo LM 1997 The epidemiology of thyroid diseases and implications for screening. Endocrinol Metab Clin North Am 26:189-218 (Pubitemid 27123901)
5. Boelaert K, Franklyn JA 2005 Thyroid hormone in health and disease. J Endocrinol 187:1-15 (Pubitemid 41556396)
6. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA 2001 Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358:861-865 (Pubitemid 32900566)
7. Bauer DC, Rodondi N, Stone KL, Hillier TA 2007 Thyroid hormone use, hyperthyroidism and mortality in older women. Am J Med 120:343-349 (Pubitemid 46483309)
8. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, Michelangeli V 2005 Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 165:2467-2472
9. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW 2006 Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295:1033-1041
10. Murphy E, Williams GR 2004 The thyroid and the skeleton. Clin Endocrinol (Oxf) 61:285-298 (Pubitemid 39287057)
11. Fö ldes J, Tarján G, Szathmari M, Varga F, Krasznai I, Horvath C 1993 Bone mineral density in patients with endogenous subclinical hyperthyroidism: is the thyroid status a risk factor for osteoporosis? Clinical Endocrinology 39:521-527
12. Bauer DC, Nevitt MC, Ettinger B, Stone K 1997 Low thyrotropin levels are not associated with bone loss in older women: a prospective study. J Clin Endocrinol Metab 82:2931-2936 (Pubitemid 27385651)
13. Flynn RW, Macdonald TM, Jung RT, Morris AD, Leese GP 2006 Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab 91:2159-2164 (Pubitemid 43854999)
14. Flynn RW, MacDonald TM, Morris AD, Jung RT, Leese GP 2004 The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population. J Clin Endocrinol Metab 89:3879-3884 (Pubitemid 39071488)
15. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D'Agostino RB 1994 Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249-1252 (Pubitemid 24333188)
16. Leese GP, Jung RT, Guthrie C, Waugh N, Browning MC 1992 Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol (Oxf) 37:500-503
17. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, Rodondi N 2008 Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 148:832-845 (Pubitemid 351786932)
18. Faber J, Galløe AM 1994 Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a metaanalysis. Eur J Endocrinol 130:350-356
19. Benseñor IM, Lotufo PA, Menezes PR, Scazufca M 2010 Subclinical hyperthyroidism and dementia: the Sao Paulo Ageing, Health Study (SPAH). BMC Public Health 10:298
20. Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA, Breteler MB 2000 Subclinical hyperthyroidism and the risk of dementia. The Rotterdam Study. Clin Endocrinol (Oxf) 53:733-737
21. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frö lich M, Westendorp RG 2004 Thyroid status, disability and cognitive function, and survival in old age. JAMA 292:2591-2599 (Pubitemid 39577515)